Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1998 Oct;91(10):534–535. doi: 10.1177/014107689809101009

Taeniasis and cysticercosis.

G C Cook 1
PMCID: PMC1296913  PMID: 10070374

Full text

PDF
534

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cantú C., Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol. 1996 Mar;53(3):233–239. doi: 10.1001/archneur.1996.00550030039021. [DOI] [PubMed] [Google Scholar]
  2. Carpio A., Santillán F., León P., Flores C., Hauser W. A. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med. 1995 Oct 9;155(18):1982–1988. [PubMed] [Google Scholar]
  3. Cook G. C. Neurocysticercosis: parasitology, clinical presentation, diagnosis, and recent advances in management. Q J Med. 1988 Aug;68(256):575–583. [PubMed] [Google Scholar]
  4. Couldwell W. T., Chandrasoma P., Apuzzo M. L., Zee C. S. Third ventricular cysticercal cyst mimicking a colloid cyst: case report. Neurosurgery. 1995 Dec;37(6):1200–1203. doi: 10.1227/00006123-199512000-00021. [DOI] [PubMed] [Google Scholar]
  5. Cruz M., Cruz I., Horton J. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):244–247. doi: 10.1016/0035-9203(91)90041-v. [DOI] [PubMed] [Google Scholar]
  6. Dumas J. L., Visy J. M., Belin C., Gaston A., Goldlust D., Dumas M. Parenchymal neurocysticercosis: follow-up and staging by MRI. Neuroradiology. 1997 Jan;39(1):12–18. doi: 10.1007/s002340050358. [DOI] [PubMed] [Google Scholar]
  7. Machnicka B., Dziemian E., Zwierz C. Detection of Taenia saginata antigens in faeces by ELISA. Appl Parasitol. 1996 Jun;37(2):106–110. [PubMed] [Google Scholar]
  8. Monteiro L., Nunes B., Mendonça D., Lopes J. Spectrum of epilepsy in neurocysticercosis: a long-term follow-up of 143 patients. Acta Neurol Scand. 1995 Jul;92(1):33–40. doi: 10.1111/j.1600-0404.1995.tb00463.x. [DOI] [PubMed] [Google Scholar]
  9. Moore A. C., Lutwick L. I., Schantz P. M., Pilcher J. B., Wilson M., Hightower A. W., Chapnick E. K., Abter E. I., Grossman J. R., Fried J. A. Seroprevalence of cysticercosis in an Orthodox Jewish community. Am J Trop Med Hyg. 1995 Nov;53(5):439–442. doi: 10.4269/ajtmh.1995.53.439. [DOI] [PubMed] [Google Scholar]
  10. Neal J. H. An endoscopic approach to cysticercosis cysts of the posterior third ventricle. Neurosurgery. 1995 May;36(5):1040–1043. doi: 10.1227/00006123-199505000-00026. [DOI] [PubMed] [Google Scholar]
  11. Sarti E., Flisser A., Schantz P. M., Gleizer M., Loya M., Plancarte A., Avila G., Allan J., Craig P., Bronfman M. Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. Am J Trop Med Hyg. 1997 Feb;56(2):127–132. doi: 10.4269/ajtmh.1997.56.127. [DOI] [PubMed] [Google Scholar]
  12. Sloan L., Schneider S., Rosenblatt J. Evaluation of enzyme-linked immunoassay for serological diagnosis of cysticercosis. J Clin Microbiol. 1995 Dec;33(12):3124–3128. doi: 10.1128/jcm.33.12.3124-3128.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sotelo J., Escobedo F., Penagos P. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol. 1988 May;45(5):532–534. doi: 10.1001/archneur.1988.00520290064015. [DOI] [PubMed] [Google Scholar]
  14. Takayanagui O. M., Lanchote V. L., Marques M. P., Bonato P. S. Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone. Ther Drug Monit. 1997 Feb;19(1):51–55. doi: 10.1097/00007691-199702000-00009. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES